Orexo announces positive data from phase 1 clinical study for OX640 - a nasal epinephrine rescue medication for allergic reactions ...Middle East

PR Newswire - News
All four investigational formulations of OX640 were extensively absorbed and rapidly achieved clinically relevant plasma levels of epinephrine Data available today indicates significantly improved stability compared to current standard of care in a broad range of temperatures Targeted...

Hence then, the article about orexo announces positive data from phase 1 clinical study for ox640 a nasal epinephrine rescue medication for allergic reactions was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo announces positive data from phase 1 clinical study for OX640 - a nasal epinephrine rescue medication for allergic reactions )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News